Browsing by Author Ziemssen, T

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
2015A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial (vol 261, pg 2101, 2014)Ziemssen, T; Bajenaru, OA; Carra, A; de Klippel, N; de Sa, JC; Edland, A; Frederiksen, JL; Heinzlef, O; Karageorgiou, KE; Delgado, RHL; Landtblom, AM; Islas, MAM; Tubridy, N; Gilgun-Sherki, Y; [Ziemssen, Tjalf] Neurol Univ Klin Klinikum Carl Gustav Carus, D-01307 Dresden, Germany; [Bajenaru, Ovidiu A.] Carol Davila Univ Med & Pharm, Bucharest, Romania; [Carra, Adriana] Hosp Britanico Buenos Aires, Buenos Aires, DF, Argentina; [de Klippel, Nina] Virga Jessaziekenhuis, Hasselt, Belgium; [de Sa, Joao Correia] Hosp Santa Maria, Lisbon, Portugal; [Edland, Astrid] Cent Hosp Buskerud, Drammen, Norway; [Frederiksen, Jette L.] Univ Copenhagen, Glostrup Hosp, Glostrup, Denmark; [Heinzlef, Olivier] Tenon Hosp, Paris, France; [Karageorgiou, Klimentini E.] Gen Hosp Athens, Athens, Greece; [Landtblom, Anne-Marie] Linkoping Univ, Dept Neurol, Linkoping, Sweden; [Landtblom, Anne-Marie] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Landtblom, Anne-Marie] Linkoping Univ, Dept Med Specialists, Motala, Sweden; [Landtblom, Anne-Marie] Linkoping Univ, Dept Med & Hlth Sci, Motala, Sweden; [Macias Islas, Miguel A.] Cent Univ Guadalajara, Guadalajara, Jalisco, Mexico; [Tubridy, Niall] Dublin Univ, Sch Med & Med Sci, Dublin, Ireland; [Gilgun-Sherki, Yossi] Teva Pharmaceut Ind Ltd, Petah Tiqwa, Israel
2015A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial (vol 261, pg 2101, 2014)Ziemssen, T; Bajenaru, OA; Carra, A; de Klippel, N; de Sa, JC; Edland, A; Frederiksen, JL; Heinzlef, O; Karageorgiou, KE; Delgado, RHL; Landtblom, AM; Islas, MAM; Tubridy, N; Gilgun-Sherki, Y; [Ziemssen, Tjalf] Neurol Univ Klin Klinikum Carl Gustav Carus, D-01307 Dresden, Germany; [Bajenaru, Ovidiu A.] Carol Davila Univ Med & Pharm, Bucharest, Romania; [Carra, Adriana] Hosp Britanico Buenos Aires, Buenos Aires, DF, Argentina; [de Klippel, Nina] Virga Jessaziekenhuis, Hasselt, Belgium; [de Sa, Joao Correia] Hosp Santa Maria, Lisbon, Portugal; [Edland, Astrid] Cent Hosp Buskerud, Drammen, Norway; [Frederiksen, Jette L.] Univ Copenhagen, Glostrup Hosp, Glostrup, Denmark; [Heinzlef, Olivier] Tenon Hosp, Paris, France; [Karageorgiou, Klimentini E.] Gen Hosp Athens, Athens, Greece; [Landtblom, Anne-Marie] Linkoping Univ, Dept Neurol, Linkoping, Sweden; [Landtblom, Anne-Marie] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Landtblom, Anne-Marie] Linkoping Univ, Dept Med Specialists, Motala, Sweden; [Landtblom, Anne-Marie] Linkoping Univ, Dept Med & Hlth Sci, Motala, Sweden; [Macias Islas, Miguel A.] Cent Univ Guadalajara, Guadalajara, Jalisco, Mexico; [Tubridy, Niall] Dublin Univ, Sch Med & Med Sci, Dublin, Ireland; [Gilgun-Sherki, Yossi] Teva Pharmaceut Ind Ltd, Petah Tiqwa, Israel
2013COPTIMIZE: a two-year observational survey of patients with relapsing remitting multiple sclerosis switching to glatiramer acetate 20 mg dailyZiemssen, T; Bajenaru, O; Carra, A; de Klippel, N; de Sa, J; Edland, A; Frederiksen, J; Heinzlef, O; Karageorgiou, K; Landtblom, AM; Islas, MM; Tubridy, N; Gilgun-Sherki, Y; [Ziemssen, T.] Klinikum Carl Gustav Carus, Dresden, Germany; [Bajenaru, O.] Carol Davila Univ Med & Pharm, Bucharest, Romania; [Carra, A.] Hosp Britan Buenos Aires, Buenos Aires, DF, Argentina; [de Klippel, N.] Virga Jessaziekenhuis, Hasselt, Belgium; [de Sa, J.] Hosp Santa Maria, Lisbon, Portugal; [Edland, A.] Cent Hosp Buskerud, Drammen, Norway; [Frederiksen, J.] Univ Copenhagen, Glostrup, Denmark; [Heinzlef, O.] Tenon Hosp, Paris, France; [Karageorgiou, K.] G Gennimatas Gen Hosp Athens, Athens, Greece; [Landtblom, A. M.] Linkoping Univ, Linkoping, Sweden; [Macias Islas, M.] Univ Guadalajara, Guadalajara 44430, Jalisco, Mexico; [Tubridy, N.] Univ Coll Dublin, Dublin 2, Ireland; [Gilgun-Sherki, Y.] Teva Pharmaceut Ind, Petah Tiqwa, Israel
2013COPTIMIZE: a two-year observational survey of patients with relapsing remitting multiple sclerosis switching to glatiramer acetate 20 mg dailyZiemssen, T; Bajenaru, O; Carra, A; de Klippel, N; de Sa, J; Edland, A; Frederiksen, J; Heinzlef, O; Karageorgiou, K; Landtblom, AM; Islas, MM; Tubridy, N; Gilgun-Sherki, Y; [Ziemssen, T.] Klinikum Carl Gustav Carus, Dresden, Germany; [Bajenaru, O.] Carol Davila Univ Med & Pharm, Bucharest, Romania; [Carra, A.] Hosp Britan Buenos Aires, Buenos Aires, DF, Argentina; [de Klippel, N.] Virga Jessaziekenhuis, Hasselt, Belgium; [de Sa, J.] Hosp Santa Maria, Lisbon, Portugal; [Edland, A.] Cent Hosp Buskerud, Drammen, Norway; [Frederiksen, J.] Univ Copenhagen, Glostrup, Denmark; [Heinzlef, O.] Tenon Hosp, Paris, France; [Karageorgiou, K.] G Gennimatas Gen Hosp Athens, Athens, Greece; [Landtblom, A. M.] Linkoping Univ, Linkoping, Sweden; [Macias Islas, M.] Univ Guadalajara, Guadalajara 44430, Jalisco, Mexico; [Tubridy, N.] Univ Coll Dublin, Dublin 2, Ireland; [Gilgun-Sherki, Y.] Teva Pharmaceut Ind, Petah Tiqwa, Israel